MétaCan
Menu
← Back to cohort

897-D Combinational treatment of reovirus and NK cells against bladder cancer cells using an intravesical therapy mimicking in vitro assay

2023· article· en· W4388048545 on OpenAlexaff
Yuree Lim, Jeehun Park, Joung Eun Lim, Minji Park, Seung Kwon Koh, Mijeong Lee, Sang‐Ki Kim, Seung‐Hwan Lee, Ki‐Hoon Song, Dong-Guk Park, Byong Chang Jeong, Duck Cho

Bibliographic record

Venuenot available
Typearticle
Languageen
FieldMedicine
TopicBladder and Urothelial Cancer Treatments
Canadian institutionsUniversity of Ottawa
Fundersnot available
KeywordsCytotoxicityOncolytic virusBladder cancerCombination therapyCancer researchIn vitroImmunotherapyK562 cellsCancerImmunologyMedicinePharmacologyInternal medicineBiologyLeukemiaBiochemistry

Abstract

fetched live from OpenAlex

Background A variety of combination treatments have been investigated to overcome the low response rate and potential resistance of bladder cancer.1 Reovirus, one of the oncolytic viruses, has been studied for bladder cancer cells (BCC). While intravesical treatment with Reovirus serves as an efficient strategy, its monotherapy has often shown modest cytotoxicity against some BCC.2 Considering that natural killer (NK) cells have emerged as a key player in BC immunotherapy,3 4 it remains clear that a combination of reovirus with NK cells will be necessary to optimize therapeutic efficacy. Methods We here investigated the anti-tumor effects of mono treatment and combination treatment at various concentrations in three types of BCC lines (5637, HT-1376, 253J-BV) using an in vitro experimental model mimicking intravesical therapy. To simulate the clinical treatment, we reduced the cytotoxicity duration to 2 hours followed by washing. In contrast, to enhance the anti-tumor effect, we utilized RP116, which is an attenuated reovirus with natural truncation of sigma 1, and interleukin (IL) 18/21-treated NK (eNK) cells expanded under stimulation with K562-mbIL-18/21 feeder cells and IL-2 and IL-15 from peripheral blood. Results Monotherapy of RP116 or IL18/21-treated eNK cells exhibited effective cytotoxicity against the 5637 (grade 1 carcinoma), but not against HT-1376 (grade 2 carcinoma) and 253J-BV (derived from a metastatic site). However, combinational treatment of IL18/21-treated eNK cells and RP116 showed effective cytotoxicity against HT-1376 and 253J-BV. Conclusions Based on these findings, the combination therapy involving reovirus and NK cells could serve as an effective treatment strategy for bladder cancer. References Peng, Mei, et al. Novel combination therapies for the treatment of bladder cancer. Front.Oncol. 2021;10 Vidal, Laura, et al. A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer. Clin Cancer Res. 2008;14:7127–37 Thangaraj, Jaya Lakshmi, et al. Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21. Cancer Immunol Immunother 2022;71(3):613–625 Bae, Woo Kyun, et al. A phase I study of locoregional high-dose autologous natural killer cell therapy with hepatic arterial infusion chemotherapy in patients with locally advanced hepatocellular carcinoma. Front. Immunol. 2022;13:879452

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.062
GPT teacher head0.337
Teacher spread0.275 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2023
Admission routes1
Has abstractyes

Explore more

Same topicBladder and Urothelial Cancer Treatments→French-language works237,207→